Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-C Wasmuth

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Journal of Molecular Medicine (Berlin, Germany)|December 5, 2020
TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patientsL Dold, L Zimmer, C Schwarze-Zander, et al.
Epidemiology and Infection|March 18, 2021
Rabies post-exposure prophylaxis in Germany - What are the challenges?P Meyerhoff, S Manekeller, N Saleh, et al.
HIV Medicine|October 31, 2020
Predictors of serofast state after treatment for early syphilis in HIV-infected patientsG Paul, J Wesselmann, D Adzic, et al.
Infection|October 2, 2013
Causes of death in HIV-infected patients from the Cologne-Bonn cohortK Ehren, C Hertenstein, T Kümmerle, et al.
Life Sciences|September 12, 2020
Parameters predicting COVID-19-induced myocardial injury and mortalityG D Duerr, A Heine, M Hamiko, et al.
Epidemiology and Infection|October 27, 2016
Measles, mumps, rubella and VZV: importance of serological testing of vaccine-preventable diseases in young adults living with HIV in GermanyC Schwarze-Zander, R Draenert, C Lehmann, et al.
HIV Medicine|June 27, 2020
Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral-naïve persons starting treatmentA Mocroft, B Neesgard, R Zangerle, et al.
Clinical and Experimental Immunology|April 24, 2013
The German national registry for primary immunodeficiencies (PID)B Gathmann, S Goldacker, M Klima, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Journal of Molecular Medicine (Berlin, Germany)|December 5, 2020
TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patientsL Dold, L Zimmer, C Schwarze-Zander, et al.
Epidemiology and Infection|March 18, 2021
Rabies post-exposure prophylaxis in Germany - What are the challenges?P Meyerhoff, S Manekeller, N Saleh, et al.
HIV Medicine|October 31, 2020
Predictors of serofast state after treatment for early syphilis in HIV-infected patientsG Paul, J Wesselmann, D Adzic, et al.
Infection|October 2, 2013
Causes of death in HIV-infected patients from the Cologne-Bonn cohortK Ehren, C Hertenstein, T Kümmerle, et al.
Life Sciences|September 12, 2020
Parameters predicting COVID-19-induced myocardial injury and mortalityG D Duerr, A Heine, M Hamiko, et al.
Epidemiology and Infection|October 27, 2016
Measles, mumps, rubella and VZV: importance of serological testing of vaccine-preventable diseases in young adults living with HIV in GermanyC Schwarze-Zander, R Draenert, C Lehmann, et al.
HIV Medicine|June 27, 2020
Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral-naïve persons starting treatmentA Mocroft, B Neesgard, R Zangerle, et al.
Clinical and Experimental Immunology|April 24, 2013
The German national registry for primary immunodeficiencies (PID)B Gathmann, S Goldacker, M Klima, et al.
Pageof 5